918 related articles for article (PubMed ID: 21150933)
1. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
3. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Haller H; Viberti GC; Mimran A; Remuzzi G; Rabelink AJ; Ritz E; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Januszewicz A
J Hypertens; 2006 Feb; 24(2):403-8. PubMed ID: 16508590
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO; Coll JR; Tran ZV; Schrier RW
Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
[TBL] [Abstract][Full Text] [Related]
5. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Ritz E; Viberti GC; Ruilope LM; Rabelink AJ; Izzo JL; Katayama S; Ito S; Mimran A; Menne J; Rump LC; Januszewicz A; Haller H
Diabetologia; 2010 Jan; 53(1):49-57. PubMed ID: 19876613
[TBL] [Abstract][Full Text] [Related]
6. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
7. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
8. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
[TBL] [Abstract][Full Text] [Related]
9. Circadian blood pressure variation in patients with type 2 diabetes--relationship to macro- and microvascular subclinical organ damage.
Jennersjö PE; Wijkman M; Wiréhn AB; Länne T; Engvall J; Nystrom FH; Östgren CJ
Prim Care Diabetes; 2011 Oct; 5(3):167-73. PubMed ID: 21546328
[TBL] [Abstract][Full Text] [Related]
10. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
[TBL] [Abstract][Full Text] [Related]
12. Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study.
Mannucci E; Lambertucci L; Monami M; Fedeli A; Chiasserini V; Marchionni N; Masotti G; Ungar A
Diabetes Metab Res Rev; 2006; 22(3):172-5. PubMed ID: 16270376
[TBL] [Abstract][Full Text] [Related]
13. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.
Smith A; Karalliedde J; De Angelis L; Goldsmith D; Viberti G
J Am Soc Nephrol; 2005 Apr; 16(4):1069-75. PubMed ID: 15743996
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
15. Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients.
Wang Y; Hu Y; Li Y; Li H; Chu S; Zhu D; Gao P
Hypertens Res; 2012 Feb; 35(2):201-6. PubMed ID: 22011684
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
[TBL] [Abstract][Full Text] [Related]
17. The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.
Menne J; Ritz E; Ruilope LM; Chatzikyrkou C; Viberti G; Haller H
J Am Heart Assoc; 2014; 3(2):e000810. PubMed ID: 24772521
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of hypertension and microalbuminuria in type 1 diabetes].
Cobuz C; Datcu G
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):52-8. PubMed ID: 20509276
[TBL] [Abstract][Full Text] [Related]
19. Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.
Menne J; Izzo JL; Ito S; Januszewicz A; Katayama S; Chatzykirkou C; Mimran A; Rabelink TJ; Ritz E; Ruilope LM; Rump LC; Viberti G; Haller H;
J Hypertens; 2012 Apr; 30(4):811-8; discussion 818. PubMed ID: 22418908
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
Clement DL; De Buyzere ML; De Bacquer DA; de Leeuw PW; Duprez DA; Fagard RH; Gheeraert PJ; Missault LH; Braun JJ; Six RO; Van Der Niepen P; O'Brien E;
N Engl J Med; 2003 Jun; 348(24):2407-15. PubMed ID: 12802026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
